AND CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES
2026 Q&A |LATEST EXAM UPDATE 2026/2027.
Core Domains:
Pharmacokinetics and Pharmacodynamics
Medication Administration and Dosage Calculation
Adverse Effects and Contraindications
Drug Interactions and Polypharmacy
Patient Education and Safety
Legal and Ethical Considerations in Pharmacology
Special Populations (Pediatric, Geriatric, Pregnancy)
Antibiotics, Antivirals, and Antifungals
Cardiovascular, Respiratory, and Neurological Medications
Endocrine and Gastrointestinal Pharmacology
Introduction:
This comprehensive practice examination is designed to assess your knowledge and clinical reasoning skills in
pharmacology, as required for the ATI Pharmacology Proctored Exam. The questions encompass foundational
pharmacological principles, medication administration, adverse effect management, patient education, and
,legal/ethical considerations. Each scenario-based question reflects real-world clinical decision-making,
emphasizing safe and effective medication practices. The examination consists of 100 multiple-choice questions
divided into one section. This resource is intended to prepare you for the rigors of the proctored examination by
reinforcing critical concepts and promoting evidence-based pharmacological interventions.
SECTION ONE: QUESTIONS 1-100
1. A nurse is preparing to administer warfarin to a client with atrial fibrillation. Which laboratory value should
the nurse monitor to evaluate the therapeutic effect of this medication?
A. Serum potassium level
B. Activated partial thromboplastin time (aPTT)
C. International normalized ratio (INR)
D. Platelet count
🟢 Correct answer: C
🔴 RATIONALE: Warfarin is an anticoagulant that works by inhibiting vitamin K-dependent clotting factors. The
INR is the standard laboratory test used to monitor and adjust warfarin therapy to maintain therapeutic
anticoagulation, typically between 2.0 and 3.0 for atrial fibrillation. aPTT is used to monitor heparin therapy.
Serum potassium and platelet count are not specific to warfarin monitoring.
,2. A client prescribed digoxin for heart failure reports nausea, vomiting, and visual disturbances with yellow
halos around lights. Which action should the nurse take first?
A. Administer an antiemetic medication
B. Hold the next dose of digoxin and obtain a serum digoxin level
C. Reassure the client that these are expected side effects
D. Increase the client's fluid intake
🟢 Correct answer: B
🔴 RATIONALE: Nausea, vomiting, and visual disturbances (yellow/green halos) are classic signs of digoxin
toxicity. The nurse should hold the next dose and assess the serum digoxin level to confirm toxicity and prevent
further complications. Digoxin toxicity can lead to life-threatening cardiac dysrhythmias and requires prompt
intervention.
3. A nurse is teaching a client about self-administering subcutaneous heparin injections. Which instruction
should the nurse include?
A. Administer the injection in the same site each time
B. Massage the site vigorously after injection to promote absorption
C. Pinch the skin fold and insert the needle at a 45- to 90-degree angle
D. Aspirate for blood return before injecting the medication
, 🟢 Correct answer: C
🔴 RATIONALE: Subcutaneous heparin should be administered by pinching the skin fold and inserting the
needle at a 45- to 90-degree angle to ensure deposition into the subcutaneous tissue. Sites should be rotated
to prevent tissue damage and hematoma formation. Massaging the site should be avoided because it can cause
bruising. Aspiration is not recommended for subcutaneous heparin administration due to risk of tissue damage.
4. A client with type 2 diabetes mellitus is prescribed metformin. Which adverse effect should the nurse
monitor for that is specific to this medication?
A. Hypoglycemia
B. Lactic acidosis
C. Weight gain
D. Respiratory depression
🟢 Correct answer: B
🔴 RATIONALE: Metformin can cause lactic acidosis, a rare but serious adverse effect characterized by elevated
lactate levels, especially in clients with renal impairment, hepatic dysfunction, or conditions that predispose to
hypoxia. Metformin does not typically cause hypoglycemia when used as monotherapy, and weight loss, not
weight gain, is more commonly associated. Respiratory depression is not a known adverse effect.